Clinical Trial Update: Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study [Phase 4]

View source ↗

Summary

Phase 4 self-controlled study assessing hydroxychloroquine sulfate for reducing proteinuria in patients with IgA nephropathy; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

Sponsor: LLiu | Conditions: Primary IgA Nephropathy | Phase 4 | Status: COMPLETED